FGFR3 and hepatocellular carcinoma: Recently, we found that FGFR3‐IIIb occurs predominantly in hepatocytes and FGFR3‐IIIc in mesenchymal liver cells and that one or both splice variants are highly overexpressed in at least 50 percent of HCC cases investigated.7